Boiron SA
BOIR.PA- Latest Trade
- trading lower40.65EUR
- Change
- -0.35
- % Change
0.85%Negative
- Day Range
- 40.55 - 41.10
- 52-Week Range
- 32.60 - 48.00
As of Jun 29 2022. Values delayed up to 15 minutes
- Previous Close
- 41.00
- Open
- 41.00
- Volume
- 891.00
- 3 Month Average Trading Volume
- 0.15
- Shares Out (Mil)
- 17.51
- Market Cap
- 719.36
- Forward P/E
- 15.37
- Dividend Yield
- 2.32
Key Statistics
1.66666667 mean rating - 3 analysts
- P/E Excl. Extra Items (TTM)
- 25.16
- Price To Sales (TTM)
- 1.58
- Price To Book (Quarterly)
- 1.35
- Price To Cash Flow (Per Share TTM)
- 17.00
- Total Debt/Total Equity (Quarterly)
- 2.37
- Long Term Debt/Equity (Quarterly)
- 1.45
- Return On Investment (TTM)
- 4.69
- Return On Equity (TTM)
- 3.68
2021 (millions USD)
About Boiron SA
Company Information
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
Address
2 avenue de l ouest LyonnaisRONTALON,
69510
France
Industry
Biotechnology & Drugs
Executive Leadership
- Thierry Boiron
- Executive Chairman of the Board
- Valerie Lorentz-Poinsot
- Chief Executive Officer, General Manager, Director
- Jean-Christophe Michel Bayssat
- Deputy Chief Executive Officer (Deputy General Manager), Chief Pharmacist, Pharmaceutical Development Director
- Jacky Abecassis
- Non-Executive Director
- Laurence Boiron
- Non-Executive Director
- Michele Boiron
- Non-Executive Director
- Jean-Pierre Boyer
- Non-Executive Director
- Christine Boyer-Boiron
- Non-Executive Director
- Stephanie Chesnot
- Non-Executive Director
- Anabelle Flory-Boiron
- Non-Executive Director
- Bruno Grange
- Non-Executive Director
- Jean-francois Henaux
- Non-Executive Director - Employees Representative
- Virginie Heurtaut
- Non-Executive Director
- Sylvain Mossaz
- Non-Executive Director - Employees Representative
- Gregory Walter
- Non-Executive Director, Representative of Shareholder Employees
- Anne Borfiga
- Non-Executive Independent Director
- Michel Bouissou
- Non-Executive Independent Director
- Philippe Brun
- Non-Executive Independent Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,830.30 | 0.70%Positive |
| Copper | 694.25 | 1.57%Negative |
| Brent Crude Oil | 119.55 | 1.33%Positive |
| CBOT Soybeans | 1,674.00 | 0.62%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,821.55 | -- |
| Euro STOXX 50 | 3,516.77 | 0.92%Negative |
| FTSE 100 | 7,322.60 | 0.01%Negative |
| Nikkei 225 | 26,804.60 | 0.91%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes